bisbenzimidazole has been researched along with oxidopamine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dragunow, M; MacGibbon, G; Walton, M; Woodgate, A | 1 |
| Akaike, A; Izumi, Y; Katsuki, H; Kume, T; Sakka, N; Sawada, H; Shimohama, S; Yamamoto, N | 1 |
| Cui, C; Ding, HF; Fan, Y; Fu, SB; Jiang, LH; Li, J; Ma, L; Sun, DJ; Yang, J; Zhang, YN | 1 |
3 other study(ies) available for bisbenzimidazole and oxidopamine
| Article | Year |
|---|---|
The toxicity of 6-hydroxydopamine on PC12 and P19 cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Aurintricarboxylic Acid; Biological Transport; Bisbenzimidazole; Carrier Proteins; Cell Membrane; Desipramine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fluorescent Dyes; Free Radical Scavengers; In Situ Nick-End Labeling; Melatonin; Membrane Glycoproteins; Membrane Transport Proteins; Necrosis; Nerve Tissue Proteins; Neurons; NG-Nitroarginine Methyl Ester; Oxidopamine; Parkinson Disease, Secondary; PC12 Cells; Rats; Sympatholytics; Tretinoin; Tritium | 1999 |
p-Quinone mediates 6-hydroxydopamine-induced dopaminergic neuronal death and ferrous iron accelerates the conversion of p-quinone into melanin extracellularly.
Topics: Analysis of Variance; Animals; Antioxidants; Benzoquinones; Bisbenzimidazole; Caspase 3; Caspases; Cell Death; Cell Survival; Cells, Cultured; Chromatography, High Pressure Liquid; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Electrochemistry; Humans; Hydrogen Peroxide; Immunohistochemistry; Iron; L-Lactate Dehydrogenase; Melanins; Mesencephalon; Models, Biological; Neuroblastoma; Neurons; Oxidopamine; Rats; Reactive Oxygen Species; Tetrazolium Salts; Thiazoles; Time Factors; Tyrosine 3-Monooxygenase | 2005 |
The Raf-1 inhibitor GW5074 and the ERK1/2 pathway inhibitor U0126 ameliorate PC12 cells apoptosis induced by 6-hydroxydopamine.
Topics: Apoptosis; Bisbenzimidazole; Blotting, Western; Butadienes; Cell Survival; Enzyme Inhibitors; Flow Cytometry; Humans; Indicators and Reagents; Indoles; MAP Kinase Signaling System; Nitriles; Oxidopamine; Parkinson Disease; PC12 Cells; Phenols; Phosphorylation; Proto-Oncogene Proteins c-raf | 2012 |